SMTC Q1 2026 Earnings EPS Surges 106 Above Estimates Yet Stock Slides 44 EGBN Q1 2026 Earnings EPS Surpasses Estimates by Over 43 Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development GBDC Q1 2026 Earnings Significant EPS Miss Amid Challenging Market Conditions MSBIP Q1 2026 Earnings Strong EPS Beat Amidst Flat Stock Reaction NEON Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement